Kala Jayaram

589 total citations
8 papers, 190 citations indexed

About

Kala Jayaram is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Kala Jayaram has authored 8 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Kala Jayaram's work include Connective tissue disorders research (6 papers), Lipid metabolism and disorders (3 papers) and Glycogen Storage Diseases and Myoclonus (1 paper). Kala Jayaram is often cited by papers focused on Connective tissue disorders research (6 papers), Lipid metabolism and disorders (3 papers) and Glycogen Storage Diseases and Myoclonus (1 paper). Kala Jayaram collaborates with scholars based in United States, Australia and United Kingdom. Kala Jayaram's co-authors include Melita Irving, Anu Cherukuri, Jonathan Day, Julie Hoover‐Fong, George Jeha, Kevin Larimore, Ravi Savarirayan, Carlos A. Bacino, Paul Harmatz and Kim‐Hanh Le Quan Sang and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Pharmacokinetics.

In The Last Decade

Kala Jayaram

7 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kala Jayaram United States 4 120 80 30 26 25 8 190
Rozeta Avetisyan United States 6 60 0.5× 127 1.6× 38 1.3× 89 3.4× 15 0.6× 7 276
Jingning Zhang United States 4 104 0.9× 85 1.1× 13 0.4× 14 0.5× 11 0.4× 7 204
Kohji Miura Japan 10 135 1.1× 137 1.7× 13 0.4× 67 2.6× 65 2.6× 18 319
Tarryn Willmer South Africa 10 49 0.4× 200 2.5× 25 0.8× 18 0.7× 47 1.9× 18 300
Sofia Bosdotter Enroth Sweden 6 62 0.5× 86 1.1× 36 1.2× 16 0.6× 16 0.6× 6 217
Nizar Ben Halim Tunisia 10 110 0.9× 109 1.4× 21 0.7× 15 0.6× 4 0.2× 22 260
Michitaka Nakagawa Japan 6 57 0.5× 169 2.1× 41 1.4× 17 0.7× 56 2.2× 11 292
Fabienne Parente France 8 60 0.5× 76 0.9× 10 0.3× 8 0.3× 8 0.3× 12 174
Helle Wulf-Johansson Denmark 8 56 0.5× 85 1.1× 21 0.7× 29 1.1× 23 0.9× 11 262
Yuya Aoto Japan 12 84 0.7× 199 2.5× 30 1.0× 9 0.3× 12 0.5× 29 324

Countries citing papers authored by Kala Jayaram

Since Specialization
Citations

This map shows the geographic impact of Kala Jayaram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kala Jayaram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kala Jayaram more than expected).

Fields of papers citing papers by Kala Jayaram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kala Jayaram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kala Jayaram. The network helps show where Kala Jayaram may publish in the future.

Co-authorship network of co-authors of Kala Jayaram

This figure shows the co-authorship network connecting the top 25 collaborators of Kala Jayaram. A scholar is included among the top collaborators of Kala Jayaram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kala Jayaram. Kala Jayaram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bowen, Alisa, Jennifer Holcomb, Tara M. Robinson, et al.. (2024). Blood biodistribution and vector shedding of valoctocogene roxaparvovec in people with severe hemophilia A. Blood Advances. 8(17). 4606–4615. 2 indexed citations
2.
Pimenta, Jeanne M., et al.. (2023). P338: Objectives and design of the Acorn Study: A non-interventional study evaluating long-term safety in achondroplasia patients treated with vosoritide. SHILAP Revista de lepidopterología. 1(1). 100366–100366. 1 indexed citations
3.
Larimore, Kevin, Anu Cherukuri, Kala Jayaram, et al.. (2021). Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia. Clinical Pharmacokinetics. 61(2). 263–280. 20 indexed citations
4.
Savarirayan, Ravi, Melita Irving, Carlos A. Bacino, et al.. (2021). Vosoritide Treatment Accelerates Bone Growth in Children with Achondroplasia. 1(3). 1 indexed citations
5.
Irving, Melita, Joel Charrow, Valérie Cormier‐Daire, et al.. (2021). Vosoritide for children with achondroplasia: a 60-month update from an ongoing phase 2 clinical trial. Molecular Genetics and Metabolism. 132. S101–S101. 4 indexed citations
6.
Savarirayan, Ravi, Melita Irving, Carlos A. Bacino, et al.. (2019). C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia. New England Journal of Medicine. 381(1). 25–35. 135 indexed citations
7.
Irving, Melita, Joel Charrow, Valérie Cormier‐Daire, et al.. (2018). Vosoritide for Children with Achondroplasia: A 30 Month Update from an Ongoing Phase 2 Clinical Trial. Hormone Research in Paediatrics. 89.
8.
Byrne, Barry J., Tarekegn Geberhiwot, Bruce A. Barshop, et al.. (2017). A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease. Orphanet Journal of Rare Diseases. 12(1). 144–144. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026